December 7, 2020, 06.27 PM

JAKARTA, – The first shipment of Covid-19 vaccine from Chinese drug maker Sinovac has arrived in Indonesia on Sunday, December 6.

In a broadcast message via the Presidential Secretariat’s official YouTube Channel, President Joko Widodo announced that the government has received 1.2 million doses of Covid-19 vaccine from China-based biopharmaceutical Company Sinovac Biotech Ltd.

“I have good news to share. Today [Sunday] the government has received 1.2 million doses of the Covid-19 vaccine,” said Jokowi, as the President is popularly known.

Also readCovid-19 Vaccine from China Will Cost Around $13, Says Indonesia’s Bio Farma

“This vaccine is produced by Sinovac and we have been testing it clinically since August 2020 in Bandung,” Jokowi said, referring to the state-owned pharmaceutical firm Bio Farma head office.

The President said there will be another shipment of 1.8 million doses of vaccine arriving in January 2021.

Besides, 45 million doses will be supplied in the form of raw materials and are expected to arrive in two batches comprising 15 million doses and 30 million doses, respectively.

“The raw materials will be further processed by Bio Farma,” he said, adding that the availability of vaccines can help prevent the spread of the Covid-19.

An illustration of Covid-19 vaccine produced by Chinese drug maker Sinovac Biotech Ltd. DW INDONESIA An illustration of Covid-19 vaccine produced by Chinese drug maker Sinovac Biotech Ltd.

Also readChina’s Sinovac Team Monitors Covid-19 Clinical Trials in Indonesia

He urged the people to continue to observe health protocols.

“Even though the vaccines have already arrived, we must be disciplined in complying with health protocols, following the 3M health protocols of mask-wearing, handwashing, and physical distancing,” said Jokowi.

He also said that all parties should follow the announcements and instructions from the relevant officers who are currently preparing the vaccination program as it is not possible to implement it simultaneously for all residents.

The Food and Drug Monitoring Agency (BPOM) will evaluate the vaccine first. “Before a mass inoculation program will take place the vaccine requires an evaluation from the Food and Drug Monitoring Agency [BPOM].” 

Also readVaccine Trial Volunteer Tests Positive for Covid-19 in Indonesia’s West Java

Indonesia through Bio Farma has collaborated with China’s Sinovac to conduct the third phase clinical trial in Bandung, West Java. The partnership between the two also involves a team from Padjajaran University in Bandung.

BPOM head Penny Lukito said that the clinical trial in Bandung went smoothly.

Penny also assured the public that the vaccine has met the halal standards following a recent examination jointly conducted by BPOM, Bio Farma, and the Indonesian Ulema Council (MUI).

Indonesia has also committed to procuring vaccines with other vaccine makers such as Sinopharm in collaboration with G42 in the United Arab Emirates, CanSino, and AstraZeneca.

(Writer: Rakhmat Nur Hakim | Editors: Kristian Erdianto, Icha Rastika)


Dapatkan update berita pilihan dan breaking news setiap hari dari Mari bergabung di Grup Telegram " News Update", caranya klik link, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

Travel & Leisure
December 6, 2022, 06.37 PM

Indonesia Never Intends to List Widi Islands for Sale

November 28, 2022, 05.16 PM

Death Toll from Indonesia Quake Rises to 321

Close Ads